الفهرس 
Polycystic ovary syndrome
Operational deign:Only 14 pages are availabe for public view
 |  | from | 133 |  |  |
| | | from | 133 | | |
Abstract
Polycystic ovary syndrome is characterised by any of oligoanovulation, clinical or biochemical hyperandrogenism, and polycystic ovaries. The syndrome affects around 4-9% of women of reproductive age. Women most commonly seek counselling or treatment because of infertility due to chronic anovulation. Insulin resistance accompanied by compensatory hyperinsulinaemia constitutes another major biochemical feature of polycystic ovary syndrome, which leads to early luteinising hormone
sensitivity of the follicle and to stimulation of both ovarian and adrenal
androgen production